168 related articles for article (PubMed ID: 31441694)
1. Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and
Kokare C; Koli D; Gadhave D; Mote C; Khandekar G
Pharm Dev Technol; 2020 Jan; 25(1):28-39. PubMed ID: 31441694
[No Abstract] [Full Text] [Related]
2. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
3. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
[TBL] [Abstract][Full Text] [Related]
4. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
5. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
[TBL] [Abstract][Full Text] [Related]
6. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
Vyas TK; Babbar AK; Sharma RK; Misra A
J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
[TBL] [Abstract][Full Text] [Related]
7. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
Belgamwar A; Khan S; Yeole P
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
[TBL] [Abstract][Full Text] [Related]
8. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
9. Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
Sharma G; Mishra AK; Mishra P; Misra A
AAPS PharmSciTech; 2009; 10(4):1321-30. PubMed ID: 19894122
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
Pokharkar V; Patil-Gadhe A; Palla P
Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):307-15. PubMed ID: 24845478
[TBL] [Abstract][Full Text] [Related]
13. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
AAPS PharmSciTech; 2006 Mar; 7(1):E49-E57. PubMed ID: 28290023
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
16. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
Shinde RL; Bharkad GP; Devarajan PV
Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
[TBL] [Abstract][Full Text] [Related]
17. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation.
Patel MR; Patel RB; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):346-54. PubMed ID: 24865295
[TBL] [Abstract][Full Text] [Related]
18. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study.
Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
Drug Deliv; 2016; 23(1):207-13. PubMed ID: 24825492
[TBL] [Abstract][Full Text] [Related]
19. PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation.
Shah P; Sarolia J; Vyas B; Wagh P; Ankur K; Kumar MA
Curr Drug Deliv; 2021; 18(6):805-824. PubMed ID: 32640955
[TBL] [Abstract][Full Text] [Related]
20. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
